ALMB-0168 reduces bone cancer growth in murine models WT Cx43; this drug also increases levels of cytotoxic lymphocytes (CD3/CD8+) and helpers (CD3/CD4+), increases the survival rate, and reduces tumor metastasis[163]. The gene discussed is CD4; the disease is neoplasm.